首页 > 市场调查报告书 > 製药

药物开发以基因为基之药物开发生物标记

市场调查报告书

商品编码

1741541

患者来源异种移植模型市场（按模型类型、移植方法、肿瘤类型、最终用户和地区划分）

Patient Derived Xenograft Model Market, By Model Type, By Implantation Method, By Tumor Type, By Application, By End User, By Geography

出版日期: 2025年03月27日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

患者来源异种移植模型市场规模预计在 2025 年达到 1.474 亿美元，预计到 2032 年将达到 4.836 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 18.5%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	1.474亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	18.50%	2032年价值预测	4.836亿美元

患者来源异种移植 (PDX) 模型是肿瘤学研究中使用的尖端临床前研究工具。在这种肿瘤模型中，癌症患者的肿瘤组织被移植到小鼠等免疫力缺乏的动物体内，以更真实地模拟人类肿瘤的行为。 PDX 模型因其能够模拟患者特异性肿瘤特征和治疗反应，在药物研发中广受欢迎。

此理论资讯部落格旨在概述患者来源的异种移植模型市场，包括其市场动态和主要特征，这将有助于相关人员了解该市场的当前和未来趋势并做出明智的决策。

市场动态：

预计未来几年，患者来源的异种移植模型市场将显着成长。推动这一市场扩张的因素有很多。首先，全球癌症发生率的上升催生了对有效治疗方案的强烈需求。 PDX 模型是研究肿瘤生物学、评估药物疗效和确定个人化治疗策略的宝贵工具。

此外，精准医疗和个人化治疗日益受到关注，也推动了PDX模型市场的成长。这些模型提供了一个平台，用于测试新型候选药物并评估特定患者群体的潜在反应。此外，製药和生物技术公司越来越多地采用PDX模型进行临床前试验，也推动了市场的成长。

然而，患者来源异种移植模型市场也面临许多挑战。主要阻碍因素之一是建立和维护PDX模型的高成本。这些模型的复杂性，包括遗传异质性以及对专业基础设施和专业知识的需求，进一步增加了整体成本。

儘管如此，该市场仍为主要企业提供了许多诱人的机会。基因组编辑工具和人源化小鼠模型等技术进步将提升PDX模型的效用和可移植性。此外，製药公司、学术机构和受託研究机构之间的合作可能会进一步加速PDX模型的普及和普及。

本研究的主要特点

这项关于患者来源异种移植模型市场的研究涵盖了各种关键特征，为市场格局提供了全面的见解，包括：

市场规模与成长：提供全球病患来源异种移植模型市场的详细分析，包括预测期 2025-2032 的市场规模（百万美国）和年复合成长率（CAGR%），假设 2024 年为基准年。
商机：它揭示了各个细分市场中的潜在商机，并提出了一系列有吸引力的投资提案，以帮助相关人员识别有利可图的机会。
市场驱动因素、限制因素和机会：它提供了对市场驱动因素、限制因素和机会的关键见解，阐明了影响机会成长的因素，并强调了新产品的发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略。
公司简介：根据公司亮点、产品系列、主要成就、财务表现、策略等参数，概述全球患者来源异种移植模型市场的主要企业。研究涵盖的公司名单包括杰克逊实验室、Champions Oncology、Charles River Laboratories、Crown Bioscience、EPO Berlin-Buch、Explora BioLabs、Hera Biolabs、Horizon Discovery Group、Oncodesign、Pharmatest Services、上海立德生物科技、Xentech、Aragen Biosciencesciencescience、Bioduro、Pharmatest Services、HirgenCdelal、Xentech、Aragen Biosciencescience、Bioduro、Cdelal、Coled、Cdelal、Xentech） Performance、无锡药明康德和安进。
决策洞察该报告为负责人和经营团队提供了宝贵的洞察，以便就产品发布、产品类型升级、市场扩张和行销策略做出明智的决策。
相关人员的利益：全球患者来源的异种移植模型市场报告针对行业中的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进入者、财务分析师等，以透过用于市场分析的各种策略矩阵促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 147.4 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	18.50%	2032 Value Projection:	USD 483.6 Mn

Patient Derived Xenograft (PDX) Model is a cutting-edge preclinical research tool used in oncology research. It is a type of tumor model where tumor tissues from cancer patients are implanted into mice or other immunodeficient animals to create a more realistic representation of the tumor's behavior in humans. PDX models have gained significant popularity in drug discovery and development due to their ability to mimic patient-specific tumor characteristics and response to treatments.

This theoretical informative blog aims to provide an overview of the Patient Derived Xenograft Model market, including its market dynamics and key features. It will assist stakeholders in understanding the current and future trends in this market and making informed decisions.

Market Dynamics:

The Patient Derived Xenograft Model market is expected to witness substantial growth in the coming years. Several factors are driving this market expansion. Firstly, the increasing prevalence of cancer globally is creating a strong demand for effective treatment options. PDX models offer a valuable tool for studying tumor biology, evaluating drug efficacy, and identifying personalized treatment strategies.

Moreover, the rising focus on precision medicine and personalized therapies further contributes to the growth of the PDX model market. These models provide a platform for testing novel drug candidates and evaluating their potential response in specific patient cohorts. Additionally, the growing adoption of PDX models by pharmaceutical and biotechnology companies for preclinical testing is boosting market growth.

However, the Patient Derived Xenograft Model market also faces some challenges. One of the key restraints is the high cost associated with creating and maintaining PDX models. The complexity of these models, including genetic heterogeneity and the need for specialized infrastructure and expertise, adds to the overall expenses.

Nevertheless, the market presents several attractive opportunities for key players. Advancements in technology, such as genome editing tools and humanized mouse models, enhance the utility and translatability of PDX models. Moreover, collaborations between pharmaceutical companies, academic research institutions, and contract research organizations are likely to further accelerate the adoption and availability of PDX models.

Key Features of the Study:

This study on the Patient Derived Xenograft Model market encompasses various essential features, providing comprehensive insights into the market landscape:

Market Size and Growth: The report offers an in-depth analysis of the global Patient Derived Xenograft Model market, including market size (in US$ Million) and compound annual growth rate (CAGR%) for the forecast period of 2025-2032, with 2024 as the base year.
Revenue Opportunities: It elucidates potential revenue opportunities across different market segments and presents attractive investment proposition matrices, aiding stakeholders in identifying lucrative opportunities.
Market Drivers, Restraints, and Opportunities: The study provides key insights into market drivers, restraints, and opportunities, shedding light on factors influencing market growth. It also highlights new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
Company Profiles: Key players in the global Patient Derived Xenograft Model market are profiled based on parameters such as company highlights, product portfolio, key achievements, financial performance, and strategies. The list of companies covered in this study includes The Jackson Laboratory, Champions Oncology, Charles River Laboratories, Crown Bioscience, EPO Berlin-Buch, Explora BioLabs, Hera Biolabs, Horizon Discovery Group, Oncodesign, Pharmatest Services, Shanghai LIDE Biotech, Xentech, Aragen Bioscience, Bioduro, Creative Animodel, Urolead, Applied StemCell, Biomodel Performance, WuXi AppTec, and Amgen.
Decision-Making Insights: The report equips marketers and management authorities with valuable insights to make informed decisions regarding product launches, type up-gradation, market expansion, and marketing tactics.
Stakeholder Benefits: The global Patient Derived Xenograft Model market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts. It provides ease in decision-making through various strategy matrices utilized in analyzing the market.

Patient Derived Xenograft Model Market Segmentation:

By Model Type
- Mice Models
- Rat Models
- Humanized Models
- Direct Patient Derived Xenograft Models
- Other Models
By Tumor Type
- Blood Cancer Models
- Solid Tumor Models
- Pediatric Tumor Models
- Other Rare Tumor Models
- Combination PDX Models
- Custom PDX Models
- Others
By Application
- Preclinical Drug Development
- Biomarker Analysis
- Personalized Medicine
- Co-Clinical Trials
- Other Research Applications
- Therapeutic Applications
By End User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
- Academic & Research Institutions
- Others
By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- The Jackson Laboratory
- Champions Oncology
- Charles River Laboratories
- Crown Bioscience
- EPO Berlin-Buch
- Explora BioLabs
- Hera Biolabs
- Horizon Discovery Group
- Oncodesign
- Pharmatest Services
- Shanghai LIDE Biotech
- Xentech
- Aragen Bioscience
- Bioduro
- Creative Animodel
- Urolead
- Applied StemCell
- Biomodel Performance
- WuXi AppTec
- Amgen

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Patient Derived Xenograft Model, By Model Type
- Market Patient Derived Xenograft Model, By Implantation Method
- Market Patient Derived Xenograft Model, By Tumor Type
- Market Patient Derived Xenograft Model, By End User
- Market Patient Derived Xenograft Model, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing Cancer Research
- Restraints
Limitations of PDX Models
- Opportunities
Applications in Immunotherapy Testing
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Patient Derived Xenograft Model Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Patient Derived Xenograft Model Market, By Model Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Tumor explant models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cell line derived models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Patient derived organoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Genetically engineered models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others (Primary cell derived models, cell processed models etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Patient Derived Xenograft Model Market, By Model Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Subcutaneous Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Orthopedic Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Patient Derived Xenograft Model Market, By Tumor Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
Gastrointestinal Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Gynecological Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Respiratory Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Other Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

8. Patient Derived Xenograft Model Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Academic & Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Million)

9. Patient Derived Xenograft Model Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

THE JACKSON LABORATORY
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Champions Oncology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hera Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Horizon Discovery Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oncodesign
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pharmatest Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Shanghai LIDE Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aragen Life Sciences Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Animodel
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Urosphere
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Applied StemCell
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

11. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

患者来源异种移植模型市场（按模型类型、移植方法、肿瘤类型、最终用户和地区划分）